AIM
GILD icon

Artemis Investment Management’s Gilead Sciences GILD Stock Holding History

Artemis Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52,961
Closed -$7.38M – 227
2026
Q1 		$7.38M Sell
52,961
-1,751
-3% -$245K 0.08% 148
2025
Q4 		$6.72M Buy
54,712
+6,988
+15% +$849K 0.08% 146
2025
Q3 		$5.3M Sell
47,724
-12,426
-21% -$1.41M 0.07% 155
2025
Q2 		$6.67M Sell
60,150
-23,404
-28% -$2.49M 0.09% 161
2025
Q1 		$9.36M Buy
+83,554
New +$8.62M 0.14% 133
2024
Q1 		– Sell
-457,565
Closed -$37.1M – 231
2023
Q4 		$37.1M Sell
457,565
-308,269
-40% -$24M 0.53% 61
2023
Q3 		$57.4M Sell
765,834
-238,381
-24% -$18.3M 0.8% 39
2023
Q2 		$77.3M Buy
1,004,215
+288,687
+40% +$23M 0.97% 27
2023
Q1 		$59.2M Buy
715,528
+605,567
+551% +$50.2M 0.73% 48
2022
Q4 		$9.49M Sell
109,961
-7,816
-7% -$619K 0.11% 144
2022
Q3 		$7.27M Buy
+117,777
New +$7.43M 0.08% 154
2021
Q4 		– Sell
-67,855
Closed -$4.74M – 287
2021
Q3 		$4.74M Sell
67,855
-209,630
-76% -$14.7M 0.04% 235
2021
Q2 		$19.1M Buy
277,485
+129,639
+88% +$8.66M 0.16% 156
2021
Q1 		$9.55M Buy
147,846
+37,090
+33% +$2.39M 0.09% 201
2020
Q4 		$6.46M Buy
110,756
+31,473
+40% +$1.9M 0.07% 222
2020
Q3 		$5.01M Sell
79,283
-969
-1% -$67.2K 0.06% 219
2020
Q2 		$6.18M Sell
80,252
-859
-1% -$65.8K 0.08% 201
2020
Q1 		$6.06K Buy
81,111
+29,837
+58% +$2.06M 0.01% 161
2019
Q4 		$3.33M Sell
51,274
-4,440
-8% -$289K 0.04% 208
2019
Q3 		$3.53M Sell
55,714
-215,372
-79% -$14.1M 0.05% 217
2019
Q2 		$18.3M Buy
271,086
+2,135
+0.8% +$140K 0.22% 137
2019
Q1 		$17.5M Sell
268,951
-135,003
-33% -$8.97M 0.2% 139
2018
Q4 		$25.3M Buy
403,954
+313,599
+347% +$21.9M 0.33% 89
2018
Q3 		$6.98M Buy
90,355
+14,188
+19% +$1.07M 0.08% 225
2018
Q2 		$5.4M Sell
76,167
-49,598
-39% -$3.5M 0.07% 196
2018
Q1 		$9.48M Buy
125,765
+23,826
+23% +$1.89M 0.15% 145
2017
Q4 		$7.3M Buy
101,939
+37,015
+57% +$2.81M 0.12% 156
2017
Q3 		$5.26M Buy
64,924
+7,754
+14% +$593K 0.11% 167
2017
Q2 		$4.05M Buy
57,170
+54,795
+2,307% +$3.65M 0.1% 168
2017
Q1 		$161K Sell
2,375
-2,829
-54% -$199K ﹤0.01% 200
2016
Q4 		$373K Hold
5,204
– – 0.01% 205
2016
Q3 		$412K Sell
5,204
-92,507
-95% -$7.51M 0.01% 200
2016
Q2 		$8.15M Sell
97,711
-334,522
-77% -$29.7M 0.22% 125
2016
Q1 		$39.7M Buy
432,233
+98,369
+29% +$8.87M 1% 24
2015
Q4 		$33.8M Buy
333,864
+7,017
+2% +$730K 0.85% 27
2015
Q3 		$32.1M Buy
326,847
+158,044
+94% +$17.6M 0.95% 22
2015
Q2 		$19.8M Buy
168,803
+107,530
+175% +$11.7M 0.64% 33
2015
Q1 		$6.01M Sell
61,273
-240,745
-80% -$24.4M 0.24% 104
2014
Q4 		$28.5M Buy
302,018
+9,811
+3% +$1.01M 1.11% 20
2014
Q3 		$31.1M Buy
+292,207
New +$28.6M 1.56% 13

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Artemis Investment Management's GILD Position: Q2 2026 in Review

Artemis Investment Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 52,961 shares — an estimated $7.38M sold.

Artemis Investment Management first reported a position in GILD in Q3 2014 and held it in 40 quarters. The position peaked at $77.3M in Q2 2023. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Artemis Investment Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Artemis Investment Management sold 52,961 Gilead Sciences shares in Q2 2026, an estimated $7.38M.
  • Artemis Investment Management first reported a position in Gilead Sciences in Q3 2014 and held it in 40 quarters.
  • Artemis Investment Management's Gilead Sciences position peaked at $77.3M in Q2 2023.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Artemis Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.